Scientists at City of Hope ® , one of the largest and most advanced cancer research and treatment organizations in the U.S.

Five-month-old Hazel Ward is battling a rare and aggressive liver cancer, and doctors say a transplant is now her best chance ...

A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

This year saw notable progress in head and neck cancers, Huntington's disease, personalized genetic therapy, and heart ...

Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and a leading ...

Twelve months later, Miller is healthy and preparing to host her family's holiday gathering. A regimen of biological drugs ...

Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, today ...

Four of the top medical leaders in Virginia have signed a letter opposing a vote last week by a Centers for Disease Control ...

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, driven by marked molecular and clinical heterogeneity and ...

As people age, their immune system function declines. T cell populations become smaller and can't react to pathogens as ...

PLT012, a groundbreaking anti-CD36 antibody, enters clinical trials to enhance immune responses in solid tumors, promising ...

A new test developed by scientists at Northwestern University could make a big difference in the fight against hepatitis C.